ACRV insider trading — Acrivon Therapeutics, Inc.
Over the last 90 days, insiders at Acrivon Therapeutics, Inc. (ACRV) made 0 open-market purchases worth $0 and 10 open-market sales worth $40K, making them net sellers by $40K. The largest sale was by Blume-Jensen Peter, Masson Kristina (President and CEO, EVP - Business Operations), who sold 14,036 shares for $31K on Aug 25, 2026.
Updated Oct 16, 2026.
Recent ACRV insider transactions
Every Form 4 filed by Acrivon Therapeutics, Inc. officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 5, 2026 | Miller Mary | Chief Legal Officer | S · Sale | Direct | 294 | $1.99 | $585 | Form 4 |
| Aug 31, 2026 | Levin Michaela | Chief Business Officer | A · Grant/award | Direct | 30,000 | — | — | Form 4 |
| Aug 25, 2026 | Blume-Jensen Peter, Masson Kristina | President and CEO, EVP - Business Operations | S · Sale | Direct | 14,036 | $2.21 | $31K | Form 4 |
| Aug 18, 2026 | Peterson Katharine | Chief Accounting Officer | S · Sale | Direct | 101 | $2.01 | $203 | Form 4 |
| Aug 18, 2026 | Miller Mary | Chief Legal Officer | S · Sale | Direct | 185 | $2.01 | $372 | Form 4 |
| Aug 18, 2026 | Gamelin Erick | Chief Development Officer | S · Sale | Direct | 400 | $2.01 | $804 | Form 4 |
| Aug 18, 2026 | Blume-Jensen Peter, Masson Kristina | President and CEO, EVP - Business Operations | S · Sale | Direct | 1,229 | $2.01 | $2K | Form 4 |
| Aug 18, 2026 | Blume-Jensen Peter, Masson Kristina | President and CEO, EVP - Business Operations | S · Sale | Indirect | 484 | $2.01 | $973 | Form 4 |
| Aug 18, 2026 | Devroe Eric | Chief Operating Officer | S · Sale | Direct | 604 | $2.01 | $1K | Form 4 |
| Aug 4, 2026 | Levy Adam D. | Chief Financial Officer | S · Sale | Direct | 1,142 | $1.57 | $2K | Form 4 |
| Jul 21, 2026 | Miller Mary | Chief Legal Officer | S · Sale | Direct | 573 | $1.76 | $1K | Form 4 |
ACRV insider trading FAQ
Are insiders buying ACRV stock?
Not on the open market. In the last 90 days, Acrivon Therapeutics, Inc. insiders made no open-market purchases, and 10 open-market sales totaling $40K. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading ACRV?
Recent sellers: Blume-Jensen Peter, Masson Kristina, Devroe Eric, Gamelin Erick, Levy Adam D., Miller Mary, Peterson Katharine.
Where does ACRV insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.